The first generation and X-rayd iffraction (XRD) analysis of ac rystalline Breslow intermediate (BI) derived from at hiazolin-2-ylidene,t hat is,t he aromatic heterocycle present in vitamin B 1 ,i sr eported. Keyt os uccess was the combined use of pentafluorobenzaldehyde and at hiazolin-2ylidene carrying an enol-stabilizing dispersion energy donor as N-substituent. Aso-called primary intermediate (PI) could be isolated in protonated form (pPI) as well and analyzed by XRD.F urthermore,t he first stable BI derived from an aromatic thiazolin-2-ylidene and an aliphatic aldehyde (trifluoroacetaldehyde) was prepared and characterized by NMR spectroscopyi ns olution. When switching to as aturated thiazolidin-2-ylidene,r eaction with pentafluorobenzaldehyde afforded an ew BI in solution (NMR spectroscopy). Attempts to crystallizet he latter BI resulted in the isolation of an ovel thiazolidin-2-ylidene dimer that had undergone rearrangement to ah exahydro[1,4]-thiazino[3,2-b]-1,4-thiazine.